HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine.

Abstract
2'-beta-Fluoro-2',3'-dideoxyadenosine (F-ddA) is an acid-stable purine dideoxynucleoside analog active against a wide spectrum of human immunodeficiency virus type 1 (HIV-1) and HIV-2 strains in vitro. F-ddA is presently undergoing a phase I clinical trial at the National Cancer Institute. We induced HIV-1 variants resistant to F-ddA by exposing wild-type HIV-1 (HIV-1LAI) to increasing concentrations of F-ddA in vitro. After 18 passages, the virus was fourfold less sensitive to F-ddA than HIV-1LAI. Sequence analyses of the passage 18 virus revealed changes in three amino acids in the reverse transcriptase (RT)-encoding region of the pol gene: P to S at codon 119 (P119S; present in 3 of 13 and 28 of 28 molecular clones before and after F-ddA exposure, respectively), V179D (0 of 13 and 9 of 28, respectively), and L214F (9 of 13 and 28 of 28, respectively). Drug sensitivity assays using recombinant infectious clones confirmed that P119S was directly responsible for the reduced sensitivity of HIV-1 to F-ddA. Various infectious clones with single or multiple amino acid substitutions conferring viral resistance against nucleoside RT inhibitors, including HIV-1 variants with multi-dideoxynucleoside resistance, were generally sensitive to F-ddA. The moderate level of resistance of HIV-1 to F-ddA, together with the lack of conferment of significant cross-resistance by the F-ddA-associated amino acid substitutions, warrants further investigation of F-ddA as a potential antiviral agent for use in treatment of HIV-1 infection.
AuthorsM Tanaka, R V Srinivas, T Ueno, M F Kavlick, F K Hui, A Fridland, J S Driscoll, H Mitsuya
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 41 Issue 6 Pg. 1313-8 (Jun 1997) ISSN: 0066-4804 [Print] United States
PMID9174190 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-HIV Agents
  • Deoxyadenine Nucleotides
  • Dideoxynucleotides
  • Reverse Transcriptase Inhibitors
  • Thymine Nucleotides
  • 2',3'-dideoxyadenosine triphosphate
  • lodenosine
  • Zidovudine
  • Dideoxyadenosine
  • zidovudine triphosphate
  • HIV Reverse Transcriptase
Topics
  • Animals
  • Anti-HIV Agents (pharmacology)
  • COS Cells
  • Deoxyadenine Nucleotides (pharmacology)
  • Dideoxyadenosine (analogs & derivatives, pharmacology)
  • Dideoxynucleotides
  • Drug Resistance, Microbial
  • Genes, pol
  • HIV Reverse Transcriptase (drug effects, metabolism)
  • HIV-1 (drug effects, genetics)
  • Humans
  • Microbial Sensitivity Tests
  • Mutation
  • Reverse Transcriptase Inhibitors (pharmacology)
  • Thymine Nucleotides (pharmacology)
  • Zidovudine (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: